Log in to save to my catalogue

Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis thro...

Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis thro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_52dc0cfc7d72406b8dc456fc310de27a

Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation

About this item

Full title

Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2021-12, Vol.13 (1), p.2-12, Article 2

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Summary
Therapies halting the progression of fibrosis are ineffective and limited. Activated myofibroblasts are emerging as important targets in the progression of fibrotic diseases. Previously, we performed a high-throughput screen on lung fibroblasts and subsequently demonstrated that the inhibition of myofibroblast activation is able to preve...

Alternative Titles

Full title

Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_52dc0cfc7d72406b8dc456fc310de27a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_52dc0cfc7d72406b8dc456fc310de27a

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-021-04439-4

How to access this item